Rs11014166
From SNPedia
| Orientation | plus |
| is a | snp |
| is | mentioned by |
| dbSNP | rs11014166 |
| PheGenI | rs11014166 |
| nextbio | rs11014166 |
| hapmap | rs11014166 |
| 1000 genomes | rs11014166 |
| hgdp | rs11014166 |
| ensembl | rs11014166 |
| gopubmed | rs11014166 |
| geneview | rs11014166 |
| scholar | rs11014166 |
| rs11014166 | |
| pharmgkb | rs11014166 |
| gwascentral | rs11014166 |
| openSNP | rs11014166 |
| 23andMe | rs11014166 |
| 23andMe all | rs11014166 |
| SNP Nexus | |
| SNPshot | rs11014166 |
| SNPdbe | rs11014166 |
| MSV3d | rs11014166 |
| Gene | CACNB2 |
| Chromosome | 10 |
| Orientation | plus |
| GMAF | 0.2033 |
| Position | 18708798 |
| Reference | GRCh37 37.1/131 |
| Max Magnitude |
| Make rs11014166(A;A) |
| Make rs11014166(A;T) |
| Make rs11014166(T;T) |
| ? | (A;A) (A;T) (T;T) | 28 |
|---|---|---|
| GWAS snp | |
|---|---|
| PMID | [PMID 19430479] |
| Trait | Diastolic Blood Pressure |
| Title | Genome-wide association study of blood pressure and hypertension |
| Risk Allele | A |
| P-val | 1E-8 |
| Odds Ratio | 0.37 [0.25-0.49] mm Hg increase |
[PMID 21156931] Genetic Variation in the {beta}2 Subunit of the Voltage-Gated Calcium Channel and Pharmacogenetic Association With Adverse Cardiovascular Outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES)
[PMID 21963141] Genetic variations in CYP17A1, CACNB2 and PLEKHA7 are associated with blood pressure and/or hypertension in she ethnic minority of China
| GET Evidence | |
|---|---|
| rs11014166 | |
| aa_change | |
| aa_change_short | |
| impact | pathogenic |
| qualified_impact | Insufficiently evaluated pathogenic |
| overall_frequency | 0.3125 |
| summary | |
